PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) has announced its participation in two upcoming investor conferences, where management will share updates on the company’s progress and engage with stakeholders.
The company will first present at the TD Cowen 45th Annual Health Care Conference in Boston, MA, on Wednesday, March 5, 2025, at 9:10 a.m. ET. The event will include both a presentation and investor meetings. Following this, Passage Bio will participate in the Leerink Global Biopharma Conference on Wednesday, March 12, 2025, at 8:00 a.m. ET in Miami, FL, offering another opportunity for stakeholders to gain insights into the company’s strategic initiatives.
Both presentations will be available via live webcast through the Investors & Media section on Passage Bio’s website. For those unable to attend, a replay will be accessible for 30 days following each event.
These conferences will provide Passage Bio with a platform to share its latest corporate developments and ongoing efforts to bring innovation in genetic medicines to patients worldwide.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.